Ads
related to: methocarbamol safe for breastfeeding adults with diabetes
Search results
Results From The WOW.Com Content Network
Methocarbamol, sold under the brand name Robaxin among others, is a medication used for short-term musculoskeletal pain. [3] [4] It may be used together with rest, physical therapy, and pain medication. [3] [5] [6] It is less preferred in low back pain. [3] It has limited use for rheumatoid arthritis and cerebral palsy.
Pre-gestational diabetes can be classified as Type 1 or Type 2 depending on the physiological mechanism. Type 1 diabetes mellitus is an autoimmune disorder leading to destruction of insulin-producing cell in the pancreas; type 2 diabetes mellitus is associated with obesity and results from a combination of insulin resistance and insufficient insulin production.
Pregnancy Risk C Lactation Risk C Adult dosage 4-4.5g q 4-6 hours. T1/2 = 0.9 - 1.8 hours Peak - 1-2 hours Approved by the American Academy of Pedriatrics for use in breastfeeding mothers. References Parmacceutical Manufacturers Package Insert, 1995 Hale. Thomas Ph.D Medication and Mothers' Milk 2000'Italic text
Contraindications to breastfeeding are those conditions that could compromise the health of the infant if breast milk from their mother is consumed. Examples include galactosemia , untreated HIV , untreated active tuberculosis , Human T-lymphotropic virus 1 or II , uses illicit drugs , or mothers undergoing chemotherapy or radiation treatment .
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Drugs used in diabetes treat types of diabetes mellitus by decreasing glucose levels in the blood. With the exception of insulin , most GLP-1 receptor agonists ( liraglutide , exenatide , and others), and pramlintide , all diabetes medications are administered orally and are thus called oral hypoglycemic agents or oral antihyperglycemic agents.
For premium support please call: 800-290-4726 more ways to reach us
Only limited data are available regarding the safety in children, youths, during pregnancy and breastfeeding. It is not known whether tolperisone is excreted into mother's milk. [3] [4] In 2012, following concerns about safety and efficacy, an "article 31 referral" [5] was triggered at the European Medicines Agency (EMA). After the review and a ...